Author: Mark Doerr

Mark Doerr is a principal and senior research analyst at Tech Insider covering medical technology companies with a focus on cardiovascular and related therapeutic technology. Mark leverages his prior experience as the director of marketing and business development at a medical device company, along with an extensive network of physician and industry relationships, to provide a unique perspective on the medtech sector. Prior to joining Tech Insider in 2011 he covered medical technology for four years at Craig-Hallum Capital, and has in total 20 years of financial and medtech industry experience.
BioTech

After-Hours Movers: Tesla (TSLA) Edges Higher After Detailing Convertible Offering; NKTR, HDSN, ISIG

Tesla (NASDAQ:TSLA) edges higher in after-hours trading, having hit another record high, at $265, in Wednesday’s regular trading session, after it files to sell $1.6 billion in convertible debt. Of the total offering, the luxury electric car maker will offer $800 million aggregate principal amount of convertible senior notes due 2019 and $800 million aggregate principal amount of convertible senior notes due 2021. Tesla intends … Continue reading After-Hours Movers: Tesla (TSLA) Edges Higher After Detailing Convertible Offering; NKTR, HDSN, ISIG

Mark Doerr
Analysis

Autodesk (NASDAQ:ADSK) Climbs After-Hours After Beating Estimates; (NASDAQ:PEIX), (NYSE:WMB)

Autodesk Inc. (NASDAQ:ADSK) rose 4.2% in extended trading after reporting earnings that beat analyst estimates. The software company’s Q4 earnings fell 25% from a year earlier to $0.40 a share, beating the Capital IQ estimate of $0.34. Revenue slipped 3.4% from a year earlier $586.6 million, beating the consensus estimate of $571 million. Autodesk estimated Q1 2015 revenue of $560 million to $575 million, compared … Continue reading Autodesk (NASDAQ:ADSK) Climbs After-Hours After Beating Estimates; (NASDAQ:PEIX), (NYSE:WMB)

Mark Doerr
BioTech, business, Earnings, Finance

Transocean (NYSE: RIG) and Dollar Tree (NASDAQ: DLTR) Highlight After-Market Earnings

Transocean Ltd. (NYSE: RIG) is due to issue its quarterly earnings report in the upcoming extended-hours session. Given its history, traders can expect very active trading in the issue immediately following its quarterly earnings announcement. Historical earnings event related premarket and after-hours trading activity in RIG indicates that the price change in the extended hours is likely to be of limited value in forecasting additional … Continue reading Transocean (NYSE: RIG) and Dollar Tree (NASDAQ: DLTR) Highlight After-Market Earnings

Mark Doerr
FB Nasdaq FB Facebook
Analysis, BioTech, business, Earnings

Trader’s Watch List: ExamWorks, JAKKS Pacific, Inc

Shares of ExamWorks (NYSE: EXAM) jumped to a new all-time high Wednesday, after the provider of independent medical examinations late Tuesday reported a narrowed Q4 net loss that was smaller than expected while revenue topped Street estimates and the company forecast Q1 and 2014 revenue above analysts’ expectations. EXAM was up 17% at $35.76 recently, after hitting the fresh record at $36.85. The company posted … Continue reading Trader’s Watch List: ExamWorks, JAKKS Pacific, Inc

Mark Doerr
FB Nasdaq FB Facebook
Analysis, news, Tech IPO

Panasonic Talks Boost Tesla (NASDAQ:TSLA) Pre-Market

Tesla (NASDAQ:TSLA) is posting gains in early pre-market trade Wednesday, gaining momentum in the wake of reports the company is in talks with Panasonic about investing nearly $1 billion in a battery factory in the U.S. Panasonic said it was considering various options to strengthen its ties with Tesla, according to multiple media reports citing the Japanese newspaper Nikkei. In Other Pre-Market News Offshore drilling … Continue reading Panasonic Talks Boost Tesla (NASDAQ:TSLA) Pre-Market

Mark Doerr
Analysis, Analyst Actions

Notable Analyst Updates – Spectranetics, HSBC, Verizon, New Home Company, Real Page

Sprectranetics (NASDAQ:SPNC) rose 10% and touched a 52-week high after the company said late Monday its trial using laser atherectomy to treat patients suffering from peripheral artery disease (PAD) had achieved statistical endpoints. Separately, Stifel Nicolas repeated its Buy recommendation on the stock and raised its price target to $30 from $24. Spectranetics, a maker of cardiovascular devices, said Monday it expects to submit a … Continue reading Notable Analyst Updates – Spectranetics, HSBC, Verizon, New Home Company, Real Page

Mark Doerr